Dermira Inc (DERM)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Dermira Inc (DERM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012927
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dermira Inc (Dermira) is a bio-pharmaceutical company which concentrates on the development and commercialization of novel therapies for the treatment of chronic skin conditions. The company concentrates on developing drugs for the treatment of diseases such as psoriasis, hyperhidrosis, atopic dermatitis and acne. Its pipeline products include cimzia, Glycopyrronium Tosylate and Olumacostat Glasaretil. Dermira’s Olumacostat Glasaretil is a topical sebum inhibitor targeting acne and sebaceous gland hyperactivity. The company’s Glycopyrronium Tosylate is a topical kinase inhibitor which targets the inflammatory skin diseases. It collaborates with biotech and pharma companies to broaden its patient access for the purpose of clinical trial of various therapeutic drugs. Dermira is headquartered in Menlo Park, California, the US.

Dermira Inc (DERM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dermira Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Dermira Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Dermira Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Dermira Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Dermira Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Dermira Inc, Medical Equipment, Deal Details 10
Partnerships 10
ImaBiotech Enters into Agreement with Dermira 10
Dermira Enters Into Licensing Agreement with Rose U 11
Equity Offering 12
Dermira Raises USD193.8 Million in Public Offering of Shares 12
Dermira Inc – Key Competitors 14
Dermira Inc – Key Employees 15
Dermira Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Nov 06, 2017: Dermira Reports Third Quarter 2017 Financial Results 18
Aug 07, 2017: Dermira Reports Second Quarter 2017 Financial Results and Provides Corporate Update 20
May 08, 2017: Dermira Reports First Quarter 2017 Financial Results and Provides Corporate Update 22
Feb 28, 2017: Dermira Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 24
Nov 07, 2016: Dermira Reports Third Quarter 2016 Financial Results and Provides Corporate Update 26
Aug 08, 2016: Dermira Reports Second Quarter 2016 Financial Results and Provides Corporate Update 28
May 10, 2016: Dermira Reports First Quarter 2016 Financial Results and Provides Corporate Update 29
Mar 03, 2016: Dermira Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update 30
Corporate Communications 32
Jun 06, 2017: Dermira Announces Appointment of Ian Clements as Vice President, Investor Relations 32
Jan 05, 2017: Lori Lyons-Williams Joins Dermira as Chief Commercial Officer 33
Jan 04, 2017: Dermira Elects Emmanuel Caeymaex to Board of Directors 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Dermira Inc, Medical Equipment, Key Facts, 2016 2
Dermira Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Dermira Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Dermira Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Dermira Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Dermira Inc, Deals By Market, 2011 to YTD 2017 8
Dermira Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ImaBiotech Enters into Agreement with Dermira 10
Dermira Enters Into Licensing Agreement with Rose U 11
Dermira Raises USD193.8 Million in Public Offering of Shares 12
Dermira Inc, Key Competitors 14
Dermira Inc, Key Employees 15

★海外企業調査レポート[Dermira Inc (DERM)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Copalis:企業の戦略・SWOT・財務情報
    Copalis - Strategy, SWOT and Corporate Finance Report Summary Copalis - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Mobile Telesystems:企業の戦略・SWOT・財務情報
    Mobile Telesystems - Strategy, SWOT and Corporate Finance Report Summary Mobile Telesystems - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Berger Paints India Ltd (BERGEPAINT):企業の財務・戦略的SWOT分析
    Berger Paints India Ltd (BERGEPAINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • La-Z-Boy Incorporated:企業の戦略・SWOT・財務情報
    La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report Summary La-Z-Boy Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SEEK Limited:企業の戦略・SWOT・財務情報
    SEEK Limited - Strategy, SWOT and Corporate Finance Report Summary SEEK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Pine Cliff Energy Ltd (PNE):企業の財務・戦略的SWOT分析
    Summary Pine Cliff Energy Ltd (Pine Cliff) is an oil and gas company that offers exploration, production, and development of natural gas, crude oil, and natural gas liquids. The company operates through its core areas such as Edson Assets, Central Assets, and Southern Assets. It acquired Hatton prop …
  • Westar Energy Inc:発電所・企業SWOT分析
    Westar Energy Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Prairie Farms Dairy Inc:企業の戦略・SWOT・財務情報
    Prairie Farms Dairy Inc - Strategy, SWOT and Corporate Finance Report Summary Prairie Farms Dairy Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Acxiom Corporation:企業の戦略・SWOT・財務分析
    Acxiom Corporation - Strategy, SWOT and Corporate Finance Report Summary Acxiom Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sandoz International GmbH:企業の戦略・SWOT・財務分析
    Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report Summary Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Liquefied Natural Gas Ltd (LNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Liquefied Natural Gas Ltd (LNGL) is an oil and gas company that constructs, plans, manages, and operates liquefied natural gas plants. The company uses the optimized single mixed refrigerant process to develop liquefied natural gas. Its optimized single mixed refrigerant process also provide …
  • XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • Bandwidth Inc (BAND):企業の財務・戦略的SWOT分析
    Bandwidth Inc (BAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):企業の財務・戦略的SWOT分析
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) carries out the manufacturing of traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, chemical medicines, dietary supplements, pharmaceutical raw mat …
  • EL Sewedy Electric Co (SWDY):電力:M&Aディール及び事業提携情報
    Summary EL Sewedy Electric Co (ELSE) is an integrated energy solutions company. It manufactures and supplies power cables, wires, insulators, transformers, terminators, joint accessories, meters and systems, telecom cables and accessories, fiber optic cables and accessories, wind blades, wind towers …
  • Kier Group plc:企業の戦略・SWOT・財務分析
    Kier Group plc - Strategy, SWOT and Corporate Finance Report Summary Kier Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • El Al Israel Airlines Ltd.:戦略・SWOT・企業財務分析
    El Al Israel Airlines Ltd. - Strategy, SWOT and Corporate Finance Report Summary El Al Israel Airlines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Hillenbrand Inc (HI):企業の財務・戦略的SWOT分析
    Hillenbrand Inc (HI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Premier Farnell Ltd:企業の戦略的SWOT分析
    Premier Farnell Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Advanced Materials Enterprises Co Ltd:企業の製品パイプライン分析2018
    Summary Advanced Materials Enterprises Co Ltd (AME) is a laboratory equipment supplier. The company manufactures group of high precision mechanical components. It offers laboratory and professional equipment, consumer and lifestyle products, industrial heating system, and healthcare products. AME’s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆